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The accumulation and propagation of misfolded
a-synuclein (a-Syn) is a central feature of Parkinson’s
disease and other synucleinopathies. Molecular
compatibility between a fibrillar seed and its native
protein state is a major determinant of amyloid self-
replication. We show that cross-seeded aggregation
of human (Hu) and mouse (Ms) a-Syn is bidirection-
ally restricted. Although fibrils formed by Hu-Ms-
a-Syn chimeric mutants can overcome this inhibition
in cell-free systems, sequence homology poorly pre-
dicts their efficiency in inducing a-Syn pathology in
primary neurons or after intracerebral injection into
wild-type mice. Chimeric a-Syn fibrils demonstrate
enhanced or reduced pathogenicities compared
with wild-type Hu- or Ms-a-Syn fibrils. Furthermore,
a-Syn mutants induced to polymerize by fibrillar
seeds inherit the functional properties of their tem-
plate, suggesting that transferable pathogenic and
non-pathogenic states likely influence the initial
engagement between exogenous a-Syn seeds and
endogenous neuronal a-Syn. Thus, transmission of
synucleinopathies is regulated by biological pro-
cesses in addition to molecular compatibility.INTRODUCTION
The propagation of misfolded proteins is an increasingly recog-
nized disease mechanism in multiple neurodegenerative disor-
ders (Jucker and Walker, 2013). Synucleinopathies, such as
Parkinson’s disease (PD), are characterized by the intracellular
accumulation of aggregated a-synuclein (a-Syn) (Lee and Troja-
nowski, 2006). Recent work indicates that fibrillar a-Syn seeds
the pathological conversion of normal neuronal a-Syn when
pathological a-Syn derived from diseased brains or recombinant
a-Syn pre-formed fibrils (PFFs) enter neurons and induces the
formation of fibrillary structures similar to Lewy bodies (LBs)
and Lewy neurites (LNs) that typify PD (Luk et al., 2012a; Reca-
sens et al., 2014; Volpicelli-Daley et al., 2011). Misfolded a-SynCell Report
This is an open access article under the CC BY-Npropagation is further enhanced by the transfer of pathological
a-Syn species from affected neurons to healthy ones (Desplats
et al., 2009; Luk et al., 2012b), suggesting that the stereotypical
spread of a-Syn pathology along neuroanatomical pathways
observed in PD patients results from a templated recruitment
process reminiscent of that described for prion diseases (Braak
et al., 2003; Dunning et al., 2013).
Despite its potentially central role in disease, little is known
about the initial steps by which pathological a-Syn seeds corrupt
native cellular a-Syn. Studies of mammalian and yeast amyloids
have established that pathological seeding across species is
generally inefficient. Resistance to cross-species templating
likely arises at the molecular level, at which sequence incompat-
ibilities result in amyloid conformations or post-translational
modifications that reduce the interface between the amyloid
seed and substrate (Angers et al., 2010; Bett et al., 2012; Jones
and Surewicz, 2005; Tessier and Lindquist, 2007). Even single
mismatches in amino acid sequence can greatly reduce the
pathogenicity of amyloids or the susceptibility of a species as
host for propagation (Santoso et al., 2000; Scott et al., 1993;
Tycko, 2015). Distinct conformational strains of fibrillar a-Syn
that induce dissimilar histopathological phenotypes have also
been identified (Bousset et al., 2013; Guo et al., 2013; Peelaerts
et al., 2015; Woerman et al., 2015), suggesting that tertiary and
quaternary structure may influence disease pathogenesis in
synucleinopathies.
The assembly kinetics of a-Syn indicate a nucleation-depen-
dent recruitment process (Biere et al., 2000; Rochet and Lans-
bury, 2000; Wood et al., 1999). Substitution of the human
sequence at either position 53 or 87 with the native mouse res-
idue accelerates fibrillization rates substantially (Kang et al.,
2011). Likewise, assembly rates for human-mouse chimeric
a-Syn proteins fall between that of the two wild-type (WT) pro-
teins and are proportional to their homology to WT mouse
(MsWT a-Syn). Past studies have focused primarily on de novo
a-Syn fibrillization in cell-free systems, although seeded fibrilliza-
tion may be particularly relevant to the cell-to-cell spread likely
occurring in PD. Recent studies showed that PFFs generated
fromMsWT a-Syn cause LBs and LNs within weeks after intrace-
rebral injection in WT mice and are more potent than WT human
(HuWT) a-Syn PFFs, which induce pathology on the scale of
months (Luk et al., 2012a; Masuda-Suzukake et al., 2013).
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MsWT andHuWT a-Syn (Figure 1A; Larsen et al., 2009) account for
this gap in seeding ability and designed a mutagenesis strategy
targeting the seven divergent positions betweenMsWT and HuWT
a-Syn to identify key residues and domains that facilitate effi-
cient templated conversion of a-Syn in vitro, in cultured neurons,
and in WT mice.
Surprisingly, although sequence homology correctly predicted
inefficient cross-seeding between HuWT andMsWT a-Syn in both
cultured neurons and in WT mice, we found that in vitro seeding
efficiencies of chimeric a-Syn PFFs correlated poorly with their
ability to induce LBs and LNs in vivo. Finally, mutant a-Syn
PFFs can confer this enhanced or reduced propagation capacity
to monomers of another sequence, providing evidence that the
ectopic seeding efficiencies observed arise from unique proper-
ties encoded within a-Syn PFF preparations.
RESULTS
Sequence Homology Predicts Efficiency of a-Syn
Cross-Seeding In Vitro
Sequence homology between a misfolded protein (i.e., a fibrillar
or oligomeric seed) and its native soluble monomer (substrate)
strongly influences the efficiency with which amyloids initiate
templated conversion (Cobb and Surewicz, 2009). From a mo-
lecular perspective, the current hypothesis supports the concept
that the rate of homologous or ‘‘self’’ recruitment (cis templating;
Figure 1B, left path) occurs faster than that of cross-seeding,
mainly because of delayed elongation caused by the reduced
trans-seeding efficacy between the non-homologous seed and
substrate. Once levels of converted substrate reach a critical
threshold, cis-seeding of this sequence becomes the dominant
kinetic factor, resulting in efficient elongation (Figure 1B, right
path).
To determine whether seeding by a-Syn PFFs also follows
such a relationship, we first confirmed that full-length HuWT,
MsWT, and a-Syn chimeras (in which divergent residues were
substituted with the orthologous amino acids) are assembly
competent (Figures 1A and S1). Following incubation with agita-
tion, all WT and chimeric a-Syn constructs formed fibrils aver-
aging 12–15 nm in diameter as observed by electron microscopy
(Figure S1B). Furthermore, PFFs showed comparable (>85%)
levels of insoluble amyloid a-Syn after sedimentation and thiofla-
vin T (ThT) binding, although ThT fluorescence intensity was not
proportional to fibril quantity (Figures S1A and S1C).
We evaluated how a-Syn sequence affects the ability of fibrils
to act as pathological seeds by comparing the relative rates of
MsWT a-Syn monomer aggregation in the presence of PFFs
made from the different a-Syn constructs. Self-seeding with
MsWT PFFs at 1% (w/w) of the monomer concentration dramat-
ically accelerated the assembly of MsWT a-Syn compared to un-
seeded reactions (Figures 1C and S2). In contrast, initiation rates
of cross-seeding reactions containing HuWT PFFs were similar to
unseeded reactions.
Chimeric PFFs seededMsWT a-Syn assembly with efficiencies
between that of HuWT and MsWT PFFs. This correlated closely
with the degree of homology between substrate and seeds but
did not achieve the cis-templating efficiency of MsWT PFFs (Fig-
ures 1C and S2). Interspecies substitutions of MsWT with the3374 Cell Reports 16, 3373–3387, September 20, 2016HuWT residue at Thr53 to Ala (MsT53A) and Asn87 to Ser
(MsN87S) respectively reduced efficiencies by 65% and 75%
compared with MsWT PFFs. Fibrils combining these two substi-
tutions (MsAS PFFs) seeded with 80% lower efficiency than
MsWT a-Syn PFFs.
Conversely, interspecies substitutions of HuWT with MsWT res-
idues increased their seeding capabilities with conversion of
Ser87 to Asn (HuS87N) having a greater effect than the A53T sub-
stitution (Figures 1C and S2). Simultaneous substitution at both
positions (HuTN) conferred an initiation rate approaching 50%
that of MsWT PFFs. Additional C-terminal substitutions, such as
Asn103 to Gly (HuTNG), had relatively minor effects on the seed-
ing efficiency of chimeric PFFs, consistent with previous studies
showing that regions immediately flanking the hydrophobic NAC
domain work in concert to influence overall in vitro fibrillization
propensity of a-Syn (Bertoncini et al., 2005). Although seeding
initiation rates varied greatly between chimeric a-Syn PFFs as
seeds, elongation rates were similar between these reactions
(Figures 1D and S2E). Thus, sequence discrepancies between
themonomer substrate (MsWT) and seeding PFFs primarily affect
the initial trans-templating event (i.e., initiation rate).
We reasoned that if differences at specific residues lead to
inefficient templating between HuWT and MsWT a-Syn, then
seeding initiation rates for WT and chimeric a-Syn PFFs should
follow the same rank order when HuWT a-Syn monomer is
used as the substrate instead of MsWT. As expected, cis-tem-
plating of HuWT a-Synmonomers byHuWT PFFswas significantly
more efficient compared with PFFs composed of other a-Syn
constructs (Figures 1E and S3). Trans-templating of HuWTmono-
mers by MsWT, HuTN, and HuTNG PFFs proceeded inefficiently,
with initiation rates similar to unseeded reactions. However,
trans-templating with MsAS PFFs, which contain human residues
at 53 and 87, was nearly as efficient as HuWT PFFs, in contrast to
the effect of converting HuWT at residues 53 and 87 to the MsWT
sequence, which effectively nullified seeding activity. These ob-
servations support the view that compatibility at these two resi-
dues greatly facilitates seed-substrate interaction. Therefore,
similar to other amyloids, the propagation of a-Syn amyloid
in vitro appears to be driven largely by individual residues rather
than unique motifs.
As observed with MsWT a-Syn monomer as the substrate,
overall elongation rates of HuWT a-Syn monomer in PFF-seeded
reactions were comparable regardless of the a-Syn sequence
encoded by the seed (Figures 1F and S3E), further supporting
the hypothesis that once a critical level of cross-seeding is
achieved, templating switches to a self-seeding mode that is
less dependent on the composition of the seed. Taken together,
although bothWT and chimeric a-Syn PFFs are capable of seed-
ing fibril formation in vitro, the initiation rates of templating are
strongly determined by sequence homology between seeds
and substrate.
Reduced Efficiency of Human-Mouse a-Syn
Cross-Seeding in Neurons
To determine if the cross-seeding properties identified in vitro
also apply to seeding in cells, we next compared the ability of
WT and chimeric a-Syn PFFs to induce LN- and LB-like inclu-
sions in cultured neurons. Consistent with our previous studies
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Figure 1. Sequence Differences between HuWT and MsWT a-Syn Reduce the Cross-Seeded Fibrillization Rate In Vitro
(A) Amino acid sequences of HuWT and MsWT a-Syn are denoted in red and black, respectively. Divergent residues are highlighted. Chimeric a-Syn proteins
contain orthologous residues at the indicated positions.
(B) Schematic of the proposed molecular mechanism for cross-seeded a-Syn aggregation. HuWT monomer (black circles) readily add to HuWT PFFs (black
wedges) through cis-templating, but recruitment of MsWT monomer (red circles) is slower because of imperfect trans-templating. Upon overcoming this initial
step, recruitment of MsWT monomer is facilitated by complete sequence homology to hybrid PFFs.
(C and E) Normalized initiation rates for 1% PFF-seeded MsWT (C) and HuWT (E) monomer. Data represent time to reach 50% aggregation.
(D and F) Normalized elongation rates (slope from 10%–90% pelletable fibrils) for 1% PFF-seeded MsWT (D) and HuWT (F).
All data are shown as mean ± SEM (n = 4). Dashed lines denote rate for unseeded reactions. One-way ANOVA (Tukey post hoc), *p < 0.05, **p < 0.01, and
***p < 0.001 versus HuWT PFFs. See also Figures S1–S3.
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(Volpicelli-Daley et al., 2011, 2014), hippocampal neurons from
non-transgenic (CD-1) mice treated with 70 nM MsWT PFFs for
7 days showed a dramatic increase in pSer129 a-Syn (pSyn; Fig-
ures 2A and 2B), a highly specific marker of LBs and LNs in hu-
man PD brains (Fujiwara et al., 2002). As predicted by in vitro
seeding data, and in agreement with cross-species seeding be-
ing inefficient, addition of HuWT PFFs at the same concentration
elicited lower levels of pSyn inclusions. HuA53T a-Syn PFFs ex-
hibited intermediate levels of LB and LN pathology that mirrored
the in vitro seeding potency of these fibrils with MsWT monomer.
Biochemical analysis of Triton X-100 soluble and insoluble a-Syn
7 days after seeding yielded results consistent with the immuno-
cytochemistry (Figures 2C and 2D). Additionally, although differ-
ences in seeding efficacy persisted, all PFFs were able to elicit
detectable levels of pathology when added to neurons at
a higher concentration (140 nM; Figure S4), indicating that
although sequence mismatches between PFF and substrate
delay the onset of pathology, insoluble inclusions develop
once seeding has been initiated.
Intriguingly, HuS87N a-Syn gave rise to PFFs whose seeding in
neurons exceeded that of MsWT PFFs (Figures 2A–2D and S4A),
even though these PFFs show a significantly slower initiation rate
in MsWT monomer than MsWT PFFs in the in vitro seeded-aggre-
gation assay (Figure 1B). Unexpectedly, HuTN PFFs elicited 94%
and 85% less pSyn than MsWT PFFs at 70 and 140 nM, respec-
tively, and were even less potent than HuWT PFFs despite
sharing more homology with endogenous MsWT a-Syn (Figures
2C, 2D, and S4) and being 2.5-fold more efficient than HuWT
PFFs in seeding MsWT monomer assembly in vitro (Figures 1C
and S2). Thus, the combination of Thr and Asn at positions 53
and 87 appears to restrict the ability to initiate pSyn inclusions
in neurons. Altogether, these observations suggest that, in
addition to sequence homology, there are biological processes
that further regulate seeding at the cellular level.
C-Terminal Modifications Further Influence a-Syn
Seeding in Neurons
Although only modest changes in in vitro seeding efficiency were
observed for chimeras containing C-terminal substitutions
beyond residue 87, the relative inactivity of HuTN PFFs in neurons
indicates that these remaining residues contribute significantly
to the seeding of MsWT PFFs in neurons. Besides positions 53
and 87, the primary sequences between HuWT and MsWT
a-Syn differ at five additional residues (100, 103, 107, 121, and
122; Figure 1A). We therefore expected that one or more addi-
tional substitutions to HuTN at these positions would have a
restorative effect on seeding when the resulting PFFs were
added to neurons. Indeed, seeding activity of HuTN PFFs could
be restored by several of the substitutions, most prominently
by reintroduction of the native mouse residue at 103 (i.e., HuTNG;
Figure S4). Although HuTNG and HuTNY PFFs show significant
rescue of seeding efficacy in neuronal culture, reintroduction of
mutations both closer to (L100M) and farther from (D121G and
N122S) the hydrophobic core of a-Syn elicited only partial recov-
ery (Figures S4C and S4E).
To further test the role of the C terminus in neuronal seeding
and its interplay with the residues at positions 53 and 87, we
generated PFFs containing only residues 1–99 of HuWT or3376 Cell Reports 16, 3373–3387, September 20, 2016MsWT a-Syn (1-99HuWT and 1-99MsWT). Treatment of neurons
with these PFFs showed significantly reduced levels of pSyn-
immunoreactive inclusions compared with full-length a-Syn
(compare HuWT and MsWT with 1-99HuWT and 1-99MsWT in Fig-
ures S4C–S4E), indicating that the C terminus facilitates efficient
seeding in neuronal cultures.
Pathological Seeding Properties of PFFs Are Preserved
In Vivo
The divergence in pathological seeding activities between
chimeric a-Syn PFFs in neurons versus cell-free assays promp-
ted us to evaluate whether PFFs have similar cross-seeding
properties in vivo. C57Bl6/C3H mice were injected with either
MsWT or HuWT PFFs by means of a single unilateral injection
into the dorsal striatum, which induces Lewy-like pathology in
multiple CNS regions connected to the injection site, including
piriform cortex (Pir), frontal agranular cortex (FC), amygdala,
and dopamine (DA) neurons of the substantia nigra pars com-
pacta (SNpc) (Luk et al., 2012a; Masuda-Suzukake et al.,
2013). As expected, MsWT PFFs induced a higher burden of
a-Syn pathology compared with HuWT PFFs when examined
by immunohistochemistry (IHC) 30 days post-injection (dpi) in
the Pir and FC, two regions that rapidly develop a-Syn inclusions
after intrastriatal PFF inoculation. Whereas LBs were present in
Pir and FC of MsWT PFF treated animals at 30 dpi, the same re-
gions in HuWT PFF-injected mice showed only traces of LN-like
accumulations, reflective of the early stages of seeded pathol-
ogy (Osterberg et al., 2015) and consistent with inefficient
cross-seeding between HuWT and MsWT a-Syn.
We then asked whether the variations in seeding observed
among chimeric PFFs in cultured neurons are preserved in vivo
by examining the distribution of a-Syn pathology in mice injected
with PFFs generated from HuS87N, HuTN, or HuTNG monomer. By
30 dpi, striatal injections of HuS87N PFFs induced abundant
a-Syn-positive LNs and LBs in ipsilateral Pir and FC (Figure 3,
second column). In contrast, mice injected with HuTN PFFs
were devoid of a-Syn pathology in all areas examined by IHC
for pSyn (Figure 3) and misfolded a-Syn (Syn506; data not
shown). The inability of HuTN PFFs to induce a-Syn pathology
was reversed by the reintroduction of the native mouse residue
at 103, as HuTNG PFFs elicited comparable levels of pathology
with HuS87N PFFs in these same regions. Thus, the induction of
Lewy-like inclusions with chimeric a-Syn PFFs in mice is more
congruent with data from our neuronal culture than from
in vitro seeding studies and further suggests that these differ-
ences are underpinned by similar cellular processes.
Notably, the mitral cell layer (MCL) of the ipsilateral olfactory
bulb, a discrete neuron population lacking direct projections to
the injection site, also showed numerous pSyn inclusions after
striatal injection of MsWT, HuS87N, and HuTNG PFFs (Figure 3, bot-
tom row). The comparable overall distribution of a-Syn pathol-
ogy induced by these PFFs also point to shared neuroanatomical
routes of spread consistent with trans-cellular spread of mis-
folded a-Syn. The MCL of mice injected with HuWT or HuTN
PFFs lacked any a-Syn pathology, suggesting that a-Syn pathol-
ogy spreads at a slower rate than with MsWT, HuS87N, or HuTNG
PFFs, consistent with a delayed initiation of aggregation in these
mice.
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Figure 2. Sequence-Dependent and Sequence-Independent Impediments to a-Syn Seeding in Neurons
(A) Immunostaining of pSyn (red) in primary hippocampal neurons treated at DIV10 for 7 days with 70 nM of indicated a-Syn PFFs. Nuclei are stained with DAPI
(blue). The scale bar represents 50 mm.
(B) Quantification of pSyn immunoreactivity in cultures ([area occupied3 density]/DAPI count). Results are shown asmean ±SEM (n = 4) relative to HuWT levels of
pSyn (dashed line).
(C) Primary hippocampal neurons treated with PFFs were sequentially extracted with 1% Triton X-100 and 2% SDS. Lysates were immunoblotted for total a-Syn
or, pSyn, with bIII tubulin (TUJ1) as a loading control.
(D) Densitometric quantification of insoluble a-Syn fractions in experiment in (C). Results are shown as mean ± SEM (n = 3).
*p < 0.05, **p < 0.01, and ***p < 0.001, one-way ANOVA versus HuWT PFF treatment (Tukey post hoc test). See also Figure S4.
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Figure 3. Cross-Seeding Efficiency of HuWT and MsWT a-Syn PFFs In Vivo
Wt mice were injected with either WT (Hu or Ms) or chimeric (HuS87N, HuTN, or HuTNG) a-Syn PFFs in a single unilateral injection into the dorsal striatum. IHC for
pSyn was used to visualize LB- and LN-like inclusions. Representative images are shown for Pir, FC, and olfactory MCL ipsilateral to the injection site at 30 dpi.
Inclusions were visible by 30 dpi in all three regions following treatment with MsWT, HuS87N, or HuTNG PFFs, whereas HuWT induced mild a-Syn accumulation in
processes (arrowheads). No pathology was detectable in animals that received HuTN PFFs. The scale bars represent 30 mm. *p < 0.05 and **p < 0.01, one-way
ANOVA versus MsWT PFF treatment (Tukey post hoc test).Chimeric a-Syn Sequences Can Enhance or Suppress
Pathological Seeding In Vivo
To more precisely determine differences in the relative seeding
by PFFs in vivo, we compared the extent of a-Syn pathology
they induced over time in the amygdala, one of the first areas
to develop LB- and LN-like pathology after intrastriatal PFF injec-
tions (Luk et al., 2012a). At 14 dpi, neurons containing pSyn were
virtually undetectable in animals inoculated with HuWT PFFs (Fig-
ures 4A–4C). By this time, however, MsWT PFF-treated animals
had accumulated considerable pSyn-positive inclusions, pri-
marily in neurites of amygdaloid nuclei. Mice injected with
HuS87N or HuTNG PFFs exhibited even more abundant LNs as
well as mature LB-like inclusions. Injection of HuA53T a-Syn
PFFs (which, like HuS87N PFFs, contain only one murine residue)
resulted in mainly LN pathology at 14 dpi, indicating that they
are less potent than either HuS87N or HuTNG PFFs in eliciting
a-Syn pathology. The rank-ordered efficiencies with which3378 Cell Reports 16, 3373–3387, September 20, 2016PFFs induced pathology in vivo are therefore consistent with
the seeding efficiency observed in culture.
Examination of PFF-injected brains at 30, 90, and 180 dpi re-
vealed that a-Syn pathology continued to evolve with time in all
mice treated with pathogenic PFFs (Figures 4B and 4C). By
30 dpi, LB-like inclusions were prominent in the amygdala of
mice exposed to HuA53T, HuS87N, HuTNG, or MsWT PFFs. How-
ever, only LN-like inclusions could be detected in HuWT PFF-in-
jectedmice, consistent with delayed initiation of seeding in these
animals. The appearance of cytoplasmic inclusions occurred at
later incubation periods (90 dpi), matching the previously
described evolution for seeded a-Syn pathology in vivo (Luk
et al., 2012a; Osterberg et al., 2015). Neuronal inclusions were
also labeled with an antibody selective for misfolded a-Syn
(Syn506; Waxman et al., 2008) and thioflavin S, confirming path-
ological a-Syn as a major constituent. However, we failed to
observe any pathology in mice injected with HuTN PFFs through
all time points up to 180 dpi, suggesting a complete lack of path-
ogenicity of these PFFs in vivo that was not observed with
neuronal cultures.
Pathogenicity of a-Syn PFFs Correlates with Rate of
Neurodegeneration In Vivo
In agreement with our previous studies, pSyn immunoreactive
inclusions could be found in ipsilateral ventral SNpc neurons
30 dpi with MsWT PFFs (Figure 5A). Comparable levels of
pSyn-positive pathologywere also seen in the SNpc following in-
jections of either HuS87N or HuTNG PFFs, whereas HuA53T PFFs
resulted in primarily LN accumulations characteristic of early
stages of seeded pathology. Inclusions were barely detectable
in DA neurons after HuWT PFF treatment, and mice inoculated
with HuTN PFFs remained free of a-Syn inclusions in all areas
examined.
Quantification of tyrosine hydroxylase-positive SNpc neurons
harboring pSyn inclusions confirmed that by 30 dpi following
injections of MsWT PFFs, pathological a-Syn deposits were
already present in28% of SNpc DA neurons (Figure 5B). Com-
parable percentages of DA neurons were affected in mice
treated with HuS87N and HuTNG PFFs (26% and 29%, respec-
tively), indicating that these PFFs likely initiate a-Syn pathology
in similar DA subpopulations. Consistent with their delayed
seeding capacities, this proportion was not reached in HuA53T
PFF-treated mice until 90 dpi, whereas less than 20% of DA neu-
rons in HuWT PFF injected animals displayed pSyn pathology at
180 dpi. Thus, with the exception of HuTN, DA cells can ultimately
be seeded by each type of PFF. Interestingly, the proportion of
SNpc neurons bearing a-Syn inclusions did not exceed 38%
after injections with PFFs of any a-Syn construct at any time
point up to 180 dpi, suggesting that templated a-Syn pathology
follows a similar trajectory of spread for pathogenic PFFs.
Because SNpc neurons that harbor a-Syn inclusions pro-
gressively degenerate in experimental studies (Luk et al.,
2012a; Paumier et al., 2015; Recasens et al., 2014), we quanti-
fied the remaining number of DA neurons in this region at each
time point to determine if the rate of inclusion formation corre-
lated with cell loss (Figures 5C and S6). The most significant
reduction in DA neurons was observed in cohorts injected
with the most pathogenic PFFs (i.e., HuS87N, HuTNG, or
MsWT), where SNpc neurons were reduced by 9%–22% at 90
dpi. This decrease approached 40% by 180 dpi, correspond-
ing to the drop in the number and proportion of pSyn-bearing
neurons at this time point (Figures 5B and 5C). Consistent
with this DA neuron loss, mice injected with HuS87N, HuTNG,
or MsWT PFFs also showed progressive deterioration in rotarod
performance that was significant by 180 dpi (Figure 5D). Impor-
tantly, neither HuWT nor HuTN PFFs caused any significant
reduction in DA neuron number up to 180 dpi.
Wild-Type and Chimeric a-Syn Fibrils Are Potent Seeds
in Non-neuronal Cells
The notable deficiency in seeding activity exhibited by HuTN
PFFs in neuron cultures and in vivo argues that its initial engage-
ment with cellular a-Syn may be the rate-limiting step. To inves-
tigate this possibility, we measured the seeding activity of WT
and chimeric PFFs in a previously established cell-model ofseeded synucleinopathy in which PFFs are delivered directly
by cationic liposomes to the cytoplasm of HEK293 cells trans-
fected with either MsWT or HuWT a-Syn (Luk et al., 2009). All
PFF preparations, including HuTN PFFs, induced a similar
amount of insoluble pSyn inclusions in cells (Figure S6). Thus,
when differences in PFF internalization and delivery are elimi-
nated, HuTN PFFs are equally potent to other PFFs in recruiting
and converting endogenous a-Syn into pathological aggregates,
consistent with observations from our in vitro seeding assays.
Non-pathogenic Chimeric a-Syn PFFs Show Normal
Entry into Neurons
Given that HuTN PFFs are highly efficient in inducing pSyn inclu-
sions when delivered into cells, yet seed poorly when passively
administered to neurons or mice, we asked if the internalization
of HuTN PFFs by neurons is compromised. We previously
showed that a-Syn PFFs are detectable in >80%of neurons after
6 hr of exposure to HuWT PFFs (Tran et al., 2014). Hippocampal
neurons derived from Snca/ mice were used to compare the
internalization efficacy of HuWT, HuTN, and MsWT PFFs at 6 and
24 hr post-transduction to eliminate confounds of detecting
endogenous a-Syn. All PFF preparations were readily internal-
ized, as indicated by detectable a-Syn positive puncta juxta-
posed to markers of early endosomes (EEA-1) and lysosomes
(LAMP1) (Figures S6D and S6E). The proportion of neurons con-
taining internalized a-Syn PFFs was similar across these three
constructs, suggesting that the lack of neuronal seeding seen
with HuTN PFFs is not due to an overall reduction in PFF entry
into neurons. Similarly, the proportions of neurons containing
a-Syn PFF in LAMP1-positive structures were indistinguishable
across these fibril types, suggesting that, at least at this early
stage, they share a common route of internalization and subcel-
lular processing (Figures S6F and S6G). No differences were
observed in the proportion of PFF-bearing neurons at 24 hr
post-treatment, further indicating that internalization is not
responsible for the inability of HuTN PFFs to induce a-Syn inclu-
sions in neurons (data not shown).
HuTN and Chimeric PFFs Display Distinct Protease
Sensitivities
Because HuTN differs in sequence from pathogenic chimeras
such as HuA53T and HuS87N by a single amino acid (aa), we tested
whether WT and chimeric PFFs assembled de novo may encode
distinct conformations. Partial digestion with various proteases
revealed several unique fragmentation patterns among PFFs.
Proteinase K (PK) treatment clearly differentiated HuWT,
HuA53T, HuS87N, and MsWT PFFs (Figure 6A). We and others
have previously shown that the five major bands following
PK digestion of HuWT PFFs consist of five polypeptides: (1) aa
1–140, (2) aa 19–140, (3) aa 32–140, (4) aa 19–120, and
(5) 32–120 (Miake et al., 2002). Several trends emerge from
the digestion patterns of PFFs as the a-Syn sequence ismodified
from HuWT to MsWT. First, increased N-terminal cleavage occurs
with perturbation of the HuWT sequence simultaneously at posi-
tions 53 and 87, resulting in a relative decline of full-length a-Syn
(band 1) compared with bands 2–5 (compare band 1 for HuTN,
HuTNG, and MsWT with HuWT, HuA53T, and HuS87N in Figure 6A).
Second, the shift from relatively equivalent amounts of bandsCell Reports 16, 3373–3387, September 20, 2016 3379
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Figure 5. a-Syn Pathology in Midbrain DA Neurons following Injections of Different a-Syn PFFs
(A) Representative images of pSyn immunoreactive inclusions accumulating in SNpc DA neurons at 30 or 90 days after inoculation with a-Syn PFFs. PFFs are
listed in order of increasing homology to MsWT a-Syn. Inclusions were detectable in all cohorts except HuTN PFFs, which remained clear of pSyn accumulation up
to 90 dpi (white arrowheads). The scale bars represent 100 mm.
(B) Quantification of the proportion of SNpc DA neurons containing pSyn-positive inclusions. Initiation of a-Syn pathology is significantly delayed in mice treated
with HuWT PFFs compared with Ms and chimeric PFFs.
(C) DA neuron number in the SNpc after treatment with indicated WT or chimeric PFFs at 30, 90, and 180 dpi. All data shown are for the hemisphere ipsilateral
to the injection site and shown as mean ± SEM (n = 5–8 per group). No inclusions were detected in the contralateral SNpc, and neuron numbers there were
unchanged for all groups.
(D) Rotarod performance of a-Syn PFF-injected mice at 30, 90, and 180 dpi with indicated PFFs.
*p < 0.05, **p < 0.01, and ***p < 0.001, two-way ANOVA (Tukey’s HSD method). See also Figure S5.2–4 in HuWT, HuA53T, and HuS87N PFF digests to a near total loss
of band 3 in the HuTN, HuTNG chimeras indicates that these res-
idue changes prevent further N-terminal truncation to generate
band 3, while facilitating cleavage at the C terminus to form
band 4 (Figures 6A and 6B). Finally, PK digestion of MsWT
PFFs shows a dramatically different pattern with rapid digestion
to band 4, indicating facile degradation at both N and C termini
(Figures 6A–6D). When comparing the digestion pattern of
HuTN and MsWT PFFs, in which only the C termini vary, reductionFigure 4. Relative Pathological Seeding Efficacy of Wt and Chimeric a
(A) Wt mice were sacrificed at 14, 30, or 90 days after intrastriatal injection of W
(B) Inclusion pathology in the ipsilateral amygdala revealed by anti-pSyn, Syn5
sequence homology to the host MsWT a-Syn from top to bottom. Pathology is de
PFF injected mice developed sparse pSyn immunoreactive processes (inset), bu
scale bars represent 50 mm.
(C) Quantification of a-Syn pathology at each time point. Data are expressed asin the stability of band 2 from Hu to Ms implies that the switch in
C-terminal residues has a collective effect in exposing the N ter-
minus of MsWT PFFs for further degradation.
Because PK treatment did not differentiate all of the PFFs
examined, particularly pro-seeding HuTNG PFFs from non-path-
ogenic HuTN PFFs, additional proteases were used.While trypsin
and chymotrypsin yielded additional differences between HuWT,
HuA53T, and HuS87N PFFs, HuTN and HuTNG PFFs continued to
lack clear differences in digestion patterns despite their starkly-Syn PFFs Is Preserved In Vivo
T or chimeric a-Syn PFFs.
06, or thioflavin S (ThS). Injected a-Syn PFFs are arranged with increasingly
tectable in mice injected with MsWT, HuS87N, and HuTNG PFFs at 14 dpi. HuA53T
t no amygdala pathology was detectable in the HuWT cohort until 30 dpi. The
mean percentage area occupied by pSyn inclusions ± SD (nR 4 per group).
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Figure 6. Protease Treatment of WT and Chimeric PFFs Reveal Distinct Digestion Patterns
(A andB)Wt and chimeric a-Syn PFFswere digested with PK (A) or Pronase E (B) at the indicated concentrations. Digestion productswere resolved on a 12%Bis-
tris gel and visualized with Coomassie Brilliant Blue. Major bands generated by each enzyme are indicated in red.
(C–G) Quantification of specific PFF digestion fragments are shown. Results represent mean band intensity relative to undigested PFFs. Data are shown as
mean ± SEM from three or more independent digestion experiments. *p < 0.05, **p < 0.01, and ***p < 0.001, two-way ANOVA (Bonferroni test), for all groups
versus HuTN, HuTNG, and MsWT (C); MsWT versus all groups (D); HuWT versus all groups (E); HuTNG versus all groups (F); and HuTN versus all groups (G).
See also Figures S5–S7.different potencies in vivo (Figure S7). However, partial digestion
with Pronase E revealed distinct patterns of protein fragments for
HuTN and HuTNG PFFs (Figures 6B and 6E–6G). HuTN PFFs
appeared to be more resistant than HuTNG PFFs at low concen-
trations (Figures 6E and 6F) but failed to build up the stable
amounts of smaller fragments prominent in digestions of all
seeding competent PFFs, including HuTNG (e.g., bands 5 and 7
in Figures 6B and 6G). Collectively, these results indicate the dif-
ferences between HuWT and MsWT PFFs are driven largely by
residues at 53 and 87, although terminal regions of a-Syn also
play an important role in the overall structure of PFFs.3382 Cell Reports 16, 3373–3387, September 20, 2016Pathological Seeding Properties of a-Syn PFFs Are
Transferrable
Because our biochemical data thus far established that HuTN and
HuWT PFFs have distinct tertiary structures and that HuTN PFFs
formed de novo are non-seeding in neurons, we determined if
these two properties are interdependent. To test whether the na-
ture of a-Syn seeds dictates PFF tertiary structure and/or
neuronal seeding ability, we seeded assembly of HuTN monomer
with 20% HuWT PFFs to generate HuTN[HuWT] PFFs (Figure 7A).
In the same manner, HuWT[HuTN] PFFs were made by seeding
monomeric HuWT with de novo HuTN fibrils. Upon PK treatment,
AB
C D
E
Figure 7. Pathogenic and Non-pathogenic Properties of PFFs Are Transferable
(A) Schematic illustrating generation of hybrid fibrils through seeding with pathogenic and non-pathogenic PFFs.
(B) Wt and chimeric a-Syn PFFs assembled de novo were digested with PK at the indicated concentrations. Digestion products in Bis-tris gels were stained with
Coomassie Brilliant Blue.
(C) Immunostaining for pSyn in primary hippocampal neurons treatedwith HuWT PFFs (140 or 28 nM to test the effect of the quantity used for seeding), HuTN[HuWT]
PFFs (20% HuWT seeded HuTN PFFs), HuTN PFFs, and HuWT[HuTN] PFFs (20%HuTN seeded HuWT PFFs) at 140 nM. Primary hippocampal neurons (DIV10) were
treated with a-Syn PFFs, and 7 days later cells were fixed and stained. Nuclei are stained with DAPI (blue). The scale bar represents 50 mM.
(D) Quantification of pSyn levels in PFF-treated neurons ([area occupied 3 average intensity]/DAPI). Results are shown as mean ± SEM (n = 3; *p < 0.05 and
**p < 0.01, one-way ANOVA versus HuWT PFF treatment with Tukey post hoc test).
(E) DIV10 primary hippocampal neurons were treated for 7 days with 140 nM PFFs and then sequentially extracted with 1% Triton X-100 followed by 2% SDS.
Lysates from Triton and SDS fractions were immunoblotted with Syn9027 (total a-Syn), MJF-R13 (pSyn), and TUJ1 loading control.
See also Figure S7.
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HuTN[HuWT] PFFs produced a banding pattern nearly identical to
that of HuWT PFFs, despite being composed primarily of HuTN
monomer (Figure 7B). Importantly, none of the bands examined
represented truncation events beyond position32 or110, ter-
minal areas in which these constructs share identical sequences,
thus eliminating the possibility that the substitutions within the
HuTN sequence were responsible for the observed differences.
Moreover, this pattern was clearly distinct from PK digestion of
de novo HuWT and HuTN PFFs mixed together just before PK
treatment. Conversely, the digestion pattern of HuWT[HuTN]
PFFs mirrored that of HuTN PFFs (Figure 7B). Thus, under these
seeding conditions, HuWT and HuTN a-Syn monomers are
capable of adopting structural properties of the templating PFFs.
To determine if HuTN[HuWT] and HuWT[HuTN] PFFs generated
by cross-seeding also inherit the pathogenicity of the templating
PFFs, we compared their ability to induce a-Syn inclusions in
hippocampal neurons (Figures 7D–7F). As predicted by its diges-
tion pattern, HuTN[HuWT] PFFs were potent in eliciting LBs and
LNs in cultured neurons (Figure 7C). Remarkably, HuTN[HuWT]
PFFs treated cultures developed approximately 4-fold more
insoluble pSyn pathology as measured by IF and immunoblot
compared with de novo aggregated HuTN PFFs, indicating that
the pathogenicity of HuWT PFFs had been successfully conferred
onto HuTN a-Syn (Figures 7D and 7E). Surprisingly, the level of
pSyn pathology induced by HuTN[HuWT] PFFs was nearly twice
the amount in cultures treated with HuWT PFFs, likely because
of the additional homology between HuTN and Ms a-Syn.
Conversely, neurons exposed to HuWT[HuTN] PFFs showed a
marked reduction in a-Syn inclusions compared with cultures
that received de novo aggregated HuWT PFFs, indicating that
HuWT had adopted the non-pathogenic state of the HuTN seeds
used to generate this material, demonstrating that both a patho-
genic and a non-pathogenic state are transferable between
different a-Syn sequences.
DISCUSSION
Recent studies have shown that misfolded a-Syn species tem-
plate the conversion of native a-Syn into pathological PD-like in-
clusions, a process that likely underlies the spread of cellular
a-Syn pathologies observed in prototypical synucleinopathies
such as PD. Although fibril-seeded LN and LB formation has
been observed in both neuron cultures and in vivo models,
how pathological a-Syn potentiates the conversion of the endog-
enous normal a-Syn pool is unclear. Our data here show that,
similar to other amyloids, PFF-mediated cross-seeding between
homologous a-Syn sequences is significantly more efficient than
that of Hu andMs a-Syn. Using a series of Hu-Ms chimeric a-Syn
PFFs, we find that at the molecular level, seeding efficiency is
determined by sequence homology between the a-Syn PFF
seeds and soluble a-Syn monomers.
However, our findings reveal a more complex picture at the
cellular level as the in vitro seeding potencies for several PFFs
did not directly correlate with their ability to induce pathology.
While Hu-Ms cross-seeding is markedly less effective when
induced by PFFs in neurons and in vivo, we also identified
chimeric a-Syn proteins that give rise to PFFs that either sig-
nificantly enhanced (HuS87N and HuTNG) or suppressed (HuTN)3384 Cell Reports 16, 3373–3387, September 20, 2016induction of a-Syn pathologies compared with MsWT a-Syn
PFFs. Among the residues examined, the two residues closest
to the core hydrophobic (NAC) domain of a-Syn (53 and 87)
show the strongest influence on PFF cross-seeding in vivo, as
highlighted by the fact that single substitutions toward resem-
bling either HuWT or MsWT immediately restore neuronal seeding
activity to HuTN PFFs, although pathogenicity is also influenced
by interactions between these two residues and the C-terminal
region (particularly around aa 103–107).
Our in vivo data also showed that these altered seeding
characteristics apply across multiple brain regions and neuronal
subtypes. Most strikingly, HuTN PFFs have a lower seeding ca-
pacity than even HuWT PFFs in both neuron culture and in vivo
despite its greater homology with Ms a-Syn and higher seeding
potency in cell-free systems. Thus, in addition to molecular
compatibility between seed and substrate, processes operating
at the cellular level also determine the efficiency of a-Syn pathol-
ogy transmission.
When cross-seeded with HuWT PFFs, HuTN monomers form
pathogenic PFFs. Similarly, HuWT monomer assembled in the
presence of non-pathogenic HuTN seeds display reduced po-
tency in neurons, making it unlikely that co-purifying contami-
nants are responsible for the different activities of seeding or
non-seeding a-Syn constructs. These data also suggest that
pathogenicity can be transferred between these two sequences
through in vitro templating, consistent with the notion that
a-Syn fibrils can assume multiple conformations (Bousset
et al., 2013; Guo et al., 2013). It is possible that specific fibril
conformations have distinct biological activities, although
further studies are needed to elucidate the relationship be-
tween structure and pathogenicity in neurons. Indeed, our
PFF preparations may potentially contain multiple misfolded
species with differing pathogenicities, and it is conceivable
that alteration of the a-Syn primary sequence could shift this
equilibrium.
Our findings present a number of possible, non-exclusive sce-
narios as to how different a-Syn seeds affect pathological a-Syn
propagation. First, PFFsmaydiffer in their ability to enter intoneu-
rons. In this regard, we did not detect differences in the internal-
ization or subcellular compartmentalization of HuTN PFFs versus
other pathogenic fibrils, although more sensitive methods are
necessary to interrogate specific differences in subcellular local-
ization or if variousPFFsdiffer in their susceptibility to intracellular
processing or degradation. Second, neuronal a-Syn is preferen-
tially localized to presynaptic vesicles and is associated with
membranes under physiological conditions, where it maintains
a different conformation than its unfolded state in cell-free sys-
tems (Dettmer et al., 2016). Therefore, monomeric a-Syn could
be highly accessible to pathological a-Syn species of various
configurations in solution (hence sequence compatibility governs
cell-free seeding rate), whereas membrane-bound a-Syn might
interfacewith only a subset of configurations such as those found
within pathogenic PFF preparations (Sidhu et al., 2016). This re-
mains to be confirmed, although in agreement with this, HuTN
PFFs efficiently induce a-Syn inclusions when transduced into
a-Syn overexpressing non-neuronal cells, suggesting a reduced
ability to interact with endogenous neuronal a-Syn. Third, patho-
genic and non-pathogenic PFFs may differ in their interaction
with as yet unknown co-factors that could facilitate pathological
a-Syn seeding in neurons (Supattapone, 2014).
It is interesting that while the species barrier for the infectious
conformer of human prion protein, which in its normal conforma-
tion is a surface glycoprotein, is particularly sensitive to changes
in the aa sequence, the phenomenon described here for a-Syn,
an intracellular protein, shows a dramatic dependence on fea-
tures beyond primary structure (Cobb and Surewicz, 2009; Col-
linge and Clarke, 2007). This suggests that where a seed and the
endogenous protein meet is a key consideration for understand-
ing how the various proteins that aggregate in neurodegenera-
tive disease propagate. Further understanding of the fate of
internalized seeding-incompetent PFFs composed of HuTN
a-Syn should help elucidate the nature of this initial interaction
and thus provide important mechanistic insights into the process
of templated a-Syn seeding in neurons.
Finally, our data showing that similar neuroanatomical regions
develop a-Syn pathology regardless of the cell-free seeding ef-
ficiency of the injected a-Syn PFFs suggest that the sequences
described here alter their ability to trigger the initial misfolding
of cellular a-Syn and are in line with a model whereby a-Syn pa-
thology is induced through seeding in trans but that subsequent
propagation proceeds through cycles of seeding in cis involving
primarily endogenous a-Syn. Consistent with this, we observed
that DA neuron degeneration was most rapid following injection
of MsWT and chimeric a-Syn PFFs with greater neuronal seeding
rates and, consequently, more quickly developing a-Syn pathol-
ogy. This observation suggests a direct relationship between the
onset of a-Syn pathology burden and neuronal toxicity. In sum-
mary, our investigation of cross-seeding between Hu and Ms
a-Syn has revealed important insights into the pathogenicity of
a protein central to neurodegeneration.
EXPERIMENTAL PROCEDURES
Animals
Wt (C57BL6/C3H) mice were obtained from the Jackson Laboratories. Primary
neuronal cultures were prepared from timed-pregnant (CD-1) mice (Charles
River Laboratories) and Snca/mice (Abeliovich et al., 2000) that were main-
tained on a C57BL6 background. All housing, breeding, and procedures were
performed according to the National Institutes of Health (NIH) Guide for the
Care and Use of Experimental Animals and approved by the University of
Pennsylvania Institutional Animal Care and Use Committee.
Recombinant a-Syn Purification and In Vitro Fibrillization
Constructs for chimeric a-Syn proteins were generated through PCR site-
directed mutagenesis with the PRK172/HuWT a-Syn or PRK172/MsWT a-Syn
plasmid as template. Wt and chimeric a-Syn constructs were expressed in
E. coli BL21 (DE3) RIL cells and purified as previously described (Giasson
et al., 2001; Luk et al., 2009, 2012a; Volpicelli-Daley et al., 2014). Fibrillization
was conducted by diluting recombinant a-Syn to 360 mM (5 mg/ml) in sterile
Dulbecco’s PBS (pH 7.0; Mediatech) with constant agitation (1,000 rpm at
37C) for 7 days in an Eppendorf Thermomixer C with ThermoTop. Successful
fibrillization was verified by sedimentation, transmission electron microscopy
(TEM) analysis, and ThT binding. Further details are described in Supplemental
Experimental Procedures.
Kinetic Analysis of Seeded a-Syn In Vitro Fibrillization
Efficacy of seeding for a particular construct was assayed by adding 1% PFFs
(25 mg/ml) into a fibrillization reaction containing 99% freshly thawed and spun
MsWT or HuWT monomer (2.5 mg/ml in the final reaction). All seeded fibrilliza-tion reactions were performed at a final concentration of 2.5 mg/ml (180 mM)
and final volume of 750 ml in order to facilitate differentiation of aggregation
rates. Sedimentation was performed at the time points indicated. For each
a-Syn construct, more than two independently prepared monomer batches
were tested for each fibrillization paradigm, and more than two series of
seeded fibrillization reactions were run for each monomer batch. Relative
quantities of protein in each fraction were assessed by densitometry using a
Li-Cor Odyssey scanner at 680 nm. Graphing was performed with GraphPad
Prism 4, and the curve-fitting feature of the software was used to generate
the elongation rate (Hill slope) and initiation rate (half maximal effective con-
centration [EC50]) data for Figures 1, S2, and S3.
Primary Neuron Cultures and Fibril Transduction
Primary neuron cultures were prepared from CD1 or Snca/mice on embry-
onic day 15 to embryonic day 17, as previously described (Volpicelli-Daley
et al., 2014). Dissociated hippocampal neurons were plated onto poly-D-lysine
coated coverslips in 24-well plates (100,000 cells/coverslip). Transductionwas
performed at 10 days in vitro (DIV) using a-Syn PFFs diluted to 2.4 mM in PBS
(without Mg2+/Ca2+) and sonicated with a Biorupter (Diagenode) at high power
for 10 cycles (30 s on, 30 s off at 10C). At 4 days post-transduction, 30%of the
media was gently aspirated from each well and replaced with 200 ml of fresh
media. For biochemical studies, PFFs (140 nM) were added to neurons in a
6-well plate containing 1 million cells per well. Transduced neurons were har-
vested for immunocytochemistry or sequential extraction at 7 days post-trans-
duction (17 DIV).
Proteolytic Digestion of PFFs
PK (P-2308), trypsin (T-9201), chymotrypsin (C-4129), and Pronase E (P-5147)
were obtained from Sigma and stock solutions prepared in water. Chymo-
trypsin was dissolved in 1 mM HCl. Ten micrograms of PFFs generated from
de novo assembly reactions were digested with the indicated concentrations
of protease in Dulbecco’s PBS. Digestions were performed in a final volume of
20 ml and incubated at 37C for either 30min (PK, trypsin) or 40min (Pronase E,
chymotrypsin). Digestions were stoppedwith 1mMPMSF or 100 mMaprotinin.
Reaction samples were then boiled with SDS-sample buffer for 5 min and
resolved on NuPAGE Novex 12% Bis-Tris gels (Invitrogen) for PK, chymo-
trypsin, and Pronase E reactions or Novex 16% Tricine gels for trypsin diges-
tions. All experiments were performed three to five timeswith at least two inde-
pendently prepared batches of PFFs. Representative images from Coomassie
stained gels are shown in Figures 6 and S7.
Stereotaxic Injection of PFFs
Prior to intrastriatal injection, PFFs were first diluted in sterile PBS and soni-
cated as described above. Mice (2–3 months old) were anesthetized with ke-
tamine hydrochloride (100mg/kg, intraperitoneal [i.p.]) and xylazine (10mg/kg,
i.p.). A single injection (5 mg PFFs) was stereotaxically injected into the striatum
(coordinates: +0.2 mm relative to Bregma, +2.0 mm from midline, +2.6 mm
beneath the dura). Injections were made with 10 ml syringes (Hamilton) at a
rate of 0.1 ml/min (2.5 ml total) with the needle in place forR5min at each target.
Animals were monitored regularly following recovery from surgery and sacri-
ficed at various pre-determined time points (14, 30, 90, and 180 dpi) by over-
dose with ketamine/xylazine. For histological studies the brain and spinal cord
were removed after transcardial perfusion with PBS and underwent overnight
postfixation in either neutral buffered formalin (Fisher Scientific) or 70%
ethanol (in 150 mM NaCl [pH 7.4]), before being processed and embedded
in paraffin.
Statistical Analysis
Data from in vitro cross-seeding reactions, neuronal culture experiments, and
immunoblot quantification were compared using GraphPad Prism software
version 4, using one-way ANOVA. Post hoc testing was performed using the
Tukey method. One-way ANOVA was also used to compare in vivo pSyn pa-
thology within select regions of interest at 30 dpi. Comparison of histopatho-
logical and behavioral data in the timed-cohort series was performed using
Stata software version 11. Means from each group were analyzed using
two-way ANOVA with a-Syn PFF treatment and incubation time as factors.
Post hoc pairwise comparisons were performed using Tukey’s honestCell Reports 16, 3373–3387, September 20, 2016 3385
significant difference (HSD) method. Results from protease digestion experi-
ments were analyzed by two-way ANOVA (a-Syn PFF and protease concentra-
tion as factors). Bonferroni correction was applied to pairwise comparisons.
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